LDZKZCHTRAJAPM-UHFFFAOYSA-N
C34H37Cl2F12N5O4 — CID 159322921
Data last refreshed: (MolForge compound catalog, from PubChem)
About LDZKZCHTRAJAPM-UHFFFAOYSA-N
LDZKZCHTRAJAPM-UHFFFAOYSA-N (PubChem CID 159322921) has the molecular formula C34H37Cl2F12N5O4 and a molecular weight of 878.58 g/mol. Its IUPAC name is 1,1,1,3,3,3-hexafluoropropan-2-yl 4-[(4-chlorophenyl)methyl]piperazine-1-carboxylate;1,1,1,3,3,3-hexafluoropropan-2-yl 4-[(5-chloro-2-pyrrolidin-1-ylphenyl)methyl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | LDZKZCHTRAJAPM-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 159322921 |
| Molecular Formula | C34H37Cl2F12N5O4 |
| Molecular Weight | 878.58 g/mol |
| Exact Mass | 877.20 |
| IUPAC Name | 1,1,1,3,3,3-hexafluoropropan-2-yl 4-[(4-chlorophenyl)methyl]piperazine-1-carboxylate;1,1,1,3,3,3-hexafluoropropan-2-yl 4-[(5-chloro-2-pyrrolidin-1-ylphenyl)methyl]piperazine-1-carboxylate |
| SMILES | O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2cc(Cl)ccc2N2CCCC2)CC1.O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(Cl)cc2)CC1 |
| InChI | InChI=1S/C19H22ClF6N3O2.C15H15ClF6N2O2/c20-14-3-4-15(28-5-1-2-6-28)13(11-14)12-27-7-9-29(10-8-27)17(30)31-16(18(21,22)23)19(24,25)26;16-11-3-1-10(2-4-11)9-23-5-7-24(8-6-23)13(25)26-12(14(17,18)19)15(20,21)22/h3-4,11,16H,1-2,5-10,12H2;1-4,12H,5-9H2 |
| InChIKey | LDZKZCHTRAJAPM-UHFFFAOYSA-N |
| XLogP | 8.77 |
| TPSA | 68.80 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 878.58 |
| LogP ≤ 5 | 8.77 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159322921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.